These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3130723)

  • 1. [Changes in the blood level of serotonin in Parkinson disease].
    Karimova MKh; Aleuov ShA
    Vopr Med Khim; 1988; 34(1):45-7. PubMed ID: 3130723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation of clinico-physiologic indices and the serotonin content of the blood of patients with parkinsonism].
    Karimova MKh; Petelin LS; Aleuov ShA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(10):50-2. PubMed ID: 3213330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Catecholamines in the blood of parkinsonism patients].
    Karaban' IN; Ianovich LA; Kudrin VS
    Vrach Delo; 1990 Sep; (9):89-91. PubMed ID: 2284785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin content of platelet enriched plasma in Parkinson patients prior and during treatment with L-3,4-dihydroxyphenylalanine (L-DOPA).
    Yamaguchi K; Tomasi L; Cote LJ; Barrett R; Yahr MD
    Biochem Med; 1972 Jun; 6(3):210-5. PubMed ID: 5041890
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serum tryptophan in cases with senile dementia, parkinsonism and normal cases].
    Lehmann J
    Lakartidningen; 1974 Mar; 71(13):1285-6. PubMed ID: 4823611
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in nocturnal sleep in parkinsonism patients treated with L-dopa].
    Bricolo A; Turella G; Mazza CA; Buffatti P; Grosslercher JC
    Sist Nerv; 1970; 22(2):181-90. PubMed ID: 4323416
    [No Abstract]   [Full Text] [Related]  

  • 7. [Preliminary results of the treatment with L-Dopa of 30 patients with Parkinsonism].
    Dumas R; Rahme M; Schott B
    J Med Lyon; 1971 Apr; 52(207):599-615. PubMed ID: 5136571
    [No Abstract]   [Full Text] [Related]  

  • 8. [Levodopa treatment in parkinsonism].
    Rinne UK; Sonninen V; Siirtola T
    Duodecim; 1971; 87(12):933-47. PubMed ID: 5088232
    [No Abstract]   [Full Text] [Related]  

  • 9. [Parkinsonism and levodopa: apropos of 300 patients followed for 2 years].
    Petit H; Chevalier-Lefebvre J; Warot P
    Lille Med; 1973 Mar; 18(3):258-67. PubMed ID: 4727492
    [No Abstract]   [Full Text] [Related]  

  • 10. A hort-term evaluation of L-dopa therapy in 34 patients with parkinsonism.
    Mones RJ; Elizan TS
    J Mt Sinai Hosp N Y; 1969; 36(6):503-15. PubMed ID: 5261089
    [No Abstract]   [Full Text] [Related]  

  • 11. L-dopa and parkinsonism.
    Okihiro MM
    Hawaii Med J; 1971; 30(5):390-2. PubMed ID: 5160226
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of parkinsonism with L-dopa].
    Chouza C; Marín C; Romero S; Gomensoro JB
    Acta Neurol Latinoam; 1970; 16(1):170-83. PubMed ID: 5538052
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of parkinsonism with L-dopa].
    Hernández Peniche J; Martínez Villar C; De León Charles C
    Rev Invest Clin; 1971; 23(2):125-32. PubMed ID: 5114336
    [No Abstract]   [Full Text] [Related]  

  • 14. [Parkinsonism and L-dopa: our 1st results].
    Warot P; Petit H; Chevalier-Lefebvre J; Herbaut G
    Lille Med; 1971 May; 16(5):765-7. PubMed ID: 5115349
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitative analysis of the effects of L-dopa on gait in 26 patients with Parkinsonism.
    Peterson CR; Calvert JC; Canzoneri J; Leavitt LA; McCutchen JJ; Schwartz L
    Am J Phys Med; 1972 Aug; 51(4):171-81. PubMed ID: 5052844
    [No Abstract]   [Full Text] [Related]  

  • 16. Levodopa in parkinsonism.
    Practitioner; 1972 May; 208(247):695-9. PubMed ID: 4560973
    [No Abstract]   [Full Text] [Related]  

  • 17. [Toulouse-Piéron test in patients with Parkinsonism treated with L-dopa].
    Megna GF; Puca FM; Leggiadro N; Micalizzi V; Pigneri MT
    Acta Neurol (Napoli); 1973; 28(2):213-22. PubMed ID: 4575429
    [No Abstract]   [Full Text] [Related]  

  • 18. Effectiveness and limitations of long-term levodopa therapy in Parkinsonism.
    Celesia GG; Barr AN
    Wis Med J; 1970 Oct; 69(10):227-9. PubMed ID: 5472626
    [No Abstract]   [Full Text] [Related]  

  • 19. [Utility of L-dopa in the treatment of Parkinson's disease and parkinsonism-like diseases].
    Herskovits E; Matera R; Gacitua EF
    Medicina (B Aires); 1972; 32(1):10-4. PubMed ID: 5019629
    [No Abstract]   [Full Text] [Related]  

  • 20. Urinary 5-S-cysteinyldopa in Parkinsonism after DOPA and carbidopa.
    Stewart RM; Miller S; Gunder M
    Acta Derm Venereol; 1983; 63(2):97-101. PubMed ID: 6189350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.